Morocco: T2S Aims for a Record Stock Market Introduction in July 2026
The T2S Group (Techniques Science Santé), a leading Moroccan medical devices company, is planning an initial public offering (IPO) on the Casablanca Stock Exchange in July 2026, with an estimated operation exceeding 1.5 billion dirhams.
This move is expected to be one of the most significant financial events of the year, particularly in a Moroccan stock market that has regained momentum since successful IPOs at the end of 2025.
A Key Player in the Medical Devices Sector
Specializing in medical equipment and solutions, T2S has established itself as the market leader in Morocco, far ahead of its direct competitors, including Vicenne, the only publicly traded company in this field, and Promamec.
The group showcases solid performance, with an operating surplus exceeding 350 million dirhams, which enhances investor interest in this forthcoming operation.
A Strategy Centered Around Shareholder Exit
According to sources cited by financial media, the operation will primarily hinge on the exit of the Pan-African investment fund Helios Investment Partners, which has been the majority shareholder since 2021.
This fund acquired control of T2S from the former associates of founder Abderraouf Sordo, who is expected to remain a key shareholder and continue steering the group’s development.
Investment Bank in Charge of the File
The operation will be supported by the investment bank from the group CFG Bank, underscoring the strategic importance of this IPO for the Moroccan market.
This IPO could also surpass recent operations, particularly those of 2025, which had played a crucial role in revitalizing the Casablanca financial market and increasing investor interest in the local scene.
